Skip to main content
. 2022 Feb 18;26:101734. doi: 10.1016/j.pmedr.2022.101734

Table 1.

Summary of publications reviewed.

Author & Year Location Gavi-supported Study design Target age cohort Sample size HPV vaccination outcomes assessed Strategies Utilized Main results of costs and effectiveness
  • I.

    Program Cost Evaluations

Alonso 2019 Mozambique Demonstration program with retrospective micro costing 10-year-old girls 2 doses: 2,791 FIG3 doses: 2,276 FIG
  • Cost per FIG

  • HPV vaccine program cost

  • School-based delivery

  • US$9.99 per FIG under the two-dose schedule

  • $17.95 per FIG under the three-dose schedule

Hidle 2018 Zimbabwe Demonstration program with retrospective cost analysis 10-year-old girls 5,724 FIG
  • Cost per FIG

  • HPV vaccine program cost

  • School-based delivery

  • Facility-based delivery

  • Outreach sites

  • Lower mean service delivery cost in schools with more girl vaccinated in each vaccination cycle.

  • Economic cost of US17.39 per FIG using school-based delivery.

Levin 2013 PeruUgandaVietnam Demonstration Program with retrospective micro costing Adolescent girls 17, 268 FIG
  • Cost per FIG

  • Cost of different HPV vaccination strategies

  • Projected financial costs of national scale-up

  • Peru: School-based delivery

  • Uganda: School-based and integrated outreach delivery

  • Vietnam: School-based and health-center-based delivery

  • The cost per vaccine dose was lowest when delivery was integrated into existing health services (US$ 1.44 per dose in Uganda)

  • The maximum number of doses administered per year was 26,798 doses resulting in 8,895 FIG using the school-based strategy in Peru

Quentin 2012 Tanzania --Sponsor-subsidized acquisition cost Demonstration program with retrospective top-down cost analysis from project’s perspective 10-to12-year-old girls (class 4 and class 6) 4,211 FIG
  • Cost per FIG

  • HPV vaccination project cost

  • Projected scale-up costs for a regional program

  • School-based delivery

  • costs of class-based vaccination were less

  • because of more eligible girls being identified and higher vaccine uptake

  • Lower costs in urban areas compared to rural areas.

  • Incremental financial cost to scale up to 50,290 primary school girls estimated at US$276,00

  • Economic cost of US$9.76 per FIG excluding vaccine cost

Soi 2019 Mozambique Demonstration program with retrospective micro costing 10-year-old girls Target population sizeYear 1: 8,556Year 2: 9,135
  • Cost per FIG

  • Total program costs

  • Projected costs for national scale-up

  • School-based delivery

  • Higher implementation costs in year one compared to year two

  • Cost per FIG: $72 in year one, $38 in year two, and $54 for entire project period

  • II.

    Cost Effectiveness Analyses

Blakely 2014 New Zealand Markov modelHealth system’s perspective 12-year-ollds National sample: 58,582
  • Health gains

  • Net costs

  • Cost effectiveness of ongoing national HPV vaccination program

  • Vaccination at school

  • Vaccination in primary care practices

  • Cost-effectiveness of current program: NZ$18,800/QALY gained

  • ICER of $34,700/QALY for school-only program compared to school + PCP

  • Net cost for current program: NZ$4.65 million for 58,582 12-year-old

  • A mandatory vaccination law for HPV is not cost-effective.

Wilson 2020 Texas, USA Markov modelPayer’s perspective Uninsured and low-income adults 1,036 received HPV vaccines
  • Cost effectiveness of comprehensive adult vaccination program; HPV vaccines included

  • Local health department working with community organizations

  • At a cost-effective threshold of $100,00, HPV vaccination was cost effective with an ICER of $79,022/LYS

  • Program ICER: $67,940/LYS

  • A community immunization program is a cost-effective investment for uninsured, low income, high-risk adults

  • III.

    Novel Interventions

Coley 2018 New York, USA Randomized controlled trial 11-to-13-year olds Intervention: 81,558Control: 80,894
  • Vaccine series initiation

  • Series continuation

  • Cost analysis

  • Population health effects

  • Reminder letters mailed by the state’s health department

  • Intervention increased vaccine initiation by 2.2% for 1st dose, 1.4% for 2nd dose, 0.01% for 3rd dose.

  • The intervention cost $30.95 for each adolescent who initiated the HPV vaccine series.

Fiks 2013 Philadelphia, USA Randomized controlled trial; cluster and patient-level randomization 11-to-17-year-old girls Total: 22,486CDS: 5,557FFI: 5680CDS + FFI: 5,561No intervention: 5,68811 clinics
  • HPV vaccine series rates

  • Time to HPV vaccine receipt

  • Incremental cost effectiveness of interventions

  • FFI

  • CDS

  • Combined (FFI + CDS)

  • CDS was most effective for initiating the HPV vaccination series, FFI promoted completion, and CDS + FFI most effectively promoted series receipt.

  • For the 3 doses of HPV vaccines, the combined intervention increased vaccination rates from 16% to 25%, from 65% to 73%, and from 63% to 76%, respectively, compared with no intervention.

  • Low incremental cost for the more effective intervention versus no intervention: $6 for CDS for HPV#1, $10 and $6 for FFI for doses 2 and 3, respectively.

Kempe 2012 Colorado, USA Multi-method study: HPV vaccine demonstration project for girls only, and randomized controlled trial for boys Sixth graders attending public schools; girls only for HPV vaccines Total: 529Girls: 265
  • Proportion that received the first dose of HPV vaccine

  • Cost per recalled child immunized

  • Immunization recall at school-based health centers

  • 59% (149/253) of girls received the first HPV vaccine dose

  • Cost ranged from $1.12 to $6.87 per recalled child immunized

Lefevere 2016 Flanders, Belgium Retrospective cohort study analyzing claims data 12-to-18-year-old girls Total: 6415Intervention: 850
  • HPV vaccine series initiation

  • Personal information campaign (PIC) only

  • Combined PIC plus financial incentives (partial reimbursement)

  • PIC significantly increased vaccination initiation, with older girls responding faster.

  • One year after the campaign the difference in percentage points for HPV vaccination initiation between intervention and control groups varied between 18.5 % and 5.1%.

  • PIC increased costs by €0.59 (price of a stamp) per girl, and €450.69 per extra girl vaccinated

Mantzari 2015 England, UK Randomized controlled trial 16-to-18-year-old girls Total: 1000
  • HPV vaccine series coverage; initiation and completion

  • Invitation letters only

  • Invitation letters plus financial incentive vouchers worth £45 (£20 for 1st dose, £5 for 2nd dose, £20 for 3rd dose)

  • Financial incentives significantly increased initial uptake of the HPV-vaccination program by ∼ 10%

  • Interventions increase series completion by ∼ 10%

Morris 2015 California, USA Randomized controlled trial 11-to-17-year-olds Intervention groups: 1,797Phone call only: 3,253Unsampled controls: 116,356
  • HPV vaccine series initiation

  • HPV vaccine series completion

  • Up-to-date (UTD) status

  • Time to UTD

  • Cost efficiency of reminder methods

  • Phone call only or phone call plus one of three reminder options:

  • Text messages

  • Email

  • Postcard

  • UTD status reach by 32.1% of text message recipients, 23.3% for postcards, 20.8% for emails, and 12.4% for participants who received enrollment phone call only.

  • Mean costs for were $4.65 per postcard, $3.09 per e-mail, and $3.09 per text message enrollees.

  • The average cost for each text recipient to become UTD was $9.63 compared to $14.86 per UTD e-mail recipient and $20.22 per UTD postcard recipient.

O’Leary 2015 Colorado, USA Randomized controlled trial 11-to-17-year-olds Intervention: 2,228Controls: 2,359
  • Uptake of any needed HPV vaccine dose

  • Missed opportunity for vaccination.

  • Cost of short messaging service (SMS)

  • Practice initiated SMS with parents choosing one of 3 options:

  • Clinic call parent to schedule

  • Parent call clinic to schedule

  • None

  • 19% of intervention group compared to 15% of the control group received at least one dose of HPV vaccine

  • Responding that the clinic should call to schedule was associated with the highest effect size for completion of all needed services.

  • Net cost ranged from $855 to $3394 per practice.

  • Average costs per child were $2.64 to $10.48.

Szilagyi 2013 New York, USA Random selection of participants. Participants select choice of intervention 11-to-17-year-olds
  • Immunization rates for preventive vaccines (HPV for girls only)

  • Mailed reminder

  • Telephone reminder

  • HPV vaccine series uptake was similar across intervention groups (27% for 1st dose, 26% for 2nd dose, and 18% to 19% for 3rd dose).

  • The intervention cost $18.78 for mailed or $16.68 for phone per adolescent per year to deliver

  • The cost per additional adolescent fully vaccinated was $463.99 for mailed and $714.98 for telephone

CDS - decision support for clinicians. FFI – family focused intervention/automated decision support to families. FIG - fully immunized girl.